本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Spruce Biosciences, Inc.

53.70
-0.6500-1.20%
盤前53.970.2700+0.50%08:47 EDT
成交量:8.85萬
成交額:486.46萬
市值:1.54億
市盈率:-1.40
高:56.08
開:54.78
低:53.09
收:54.35
52周最高:240.00
52周最低:7.26
股本:287.40萬
流通股本:228.65萬
量比:0.70
換手率:3.87%
股息:- -
股息率:- -
每股收益(TTM):-38.4300
每股收益(LYR):-50.8298
淨資產收益率:-105.98%
總資產收益率:-40.03%
市淨率:1.84
市盈率(LYR):-1.06

資料載入中...

2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/06

重要事件披露

8-K - Current report
2020/12/18

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/11/18

重要事件披露

8-K - Current report
2020/11/18

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/23

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/10/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/16

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/10/16

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/10/14

重要事件披露

8-K - Current report
2020/10/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/10/06

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/06

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/05

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/18

SEC問詢函

CORRESP [Cover] - Correspondence